Design
Review
Authors
Loading...
May inform LPL-targeted therapies for dyslipidemia; leaves open whether S447X confers clinical cardiovascular protection.
Key points are not available for this paper at this time.
Rip et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: